NCT05088356
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft treatment 1 recruiting NCT03720392
Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT) No drug interventions treatment 2 terminated NCT04423939
ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients No drug interventions supportive_care Not Available active_not_recruiting NCT04332341
Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation treatment 0 recruiting NCT03302754
Precision Dosing of Alemtuzumab other Not Available completed NCT05501756
Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation treatment 2 recruiting NCT02506231
The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome prevention 2 / 3 unknown_status NCT04117477
Xylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients prevention 2 terminated NCT03678493
A Study of FMT in Patients With AML Allo HSCT in Recipients treatment 2 completed NCT00888316
Iron Overload in Patients Undergoing Donor Stem Cell Transplant No drug interventions Not Available Not Available completed NCT04088760
TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders No drug interventions treatment 2 terminated NCT03394365
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy treatment 3 recruiting NCT01903928
A Study to Evaluate Safety and Tolerability of a Therapeutic Vaccine, ASP0113, in Subjects Undergoing Allogeneic Hematopoietic Cell Transplant No drug interventions treatment 2 completed NCT04926194
Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm No drug interventions treatment 2 completed NCT04554914
A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases treatment 2 recruiting NCT01877655
A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) No drug interventions prevention 3 completed NCT06093867
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available recruiting NCT05534620
Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics other 1 recruiting NCT01420562
Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis No drug interventions Not Available Not Available recruiting NCT04995653
A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT treatment 1 completed NCT05667402
Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia No drug interventions treatment Not Available not_yet_recruiting NCT03378102
Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation No drug interventions supportive_care 0 recruiting NCT04098653
Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT treatment 2 / 3 unknown_status NCT03530085
Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT treatment 2 / 3 unknown_status NCT02670252
BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT treatment 3 completed NCT05453552
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT treatment 2 / 3 recruiting NCT02250300
MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation treatment 1 / 2 completed NCT05449899
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT treatment 2 / 3 recruiting NCT05692713
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) No drug interventions Not Available Not Available recruiting NCT03902041
The Prospective Randomized Controlled Study of Eltrombopag on Hematopoietic Reconstruction After Allogeneic HSCT Not Available Not Available unknown_status NCT03294824
Non Randomized Comparative Study With Control No drug interventions Not Available Not Available unknown_status NCT02653196
A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors treatment 0 terminated NCT05126186
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure No drug interventions other 2 not_yet_recruiting NCT05327673
Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of Life, Determinants of Choices and Financial Repercussions No drug interventions Not Available Not Available not_yet_recruiting NCT05084027
Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT treatment 2 recruiting NCT03596892
Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT treatment 2 / 3 unknown_status NCT03357172
Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions other Not Available recruiting NCT01879072
Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202) No drug interventions Not Available Not Available completed NCT05596968
The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT Not Available Not Available recruiting NCT02270346
Inspiratory Muscle Training in Allogeneic Hematopoietic Stem Cell Transplantation Recipients No drug interventions supportive_care Not Available completed NCT03384212
CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AML treatment 3 unknown_status NCT02728895
Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT treatment 1 completed NCT05823714
Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT No drug interventions treatment 2 recruiting NCT05089838
CMV-TCR-T Cells for Refractory CMV Infection After HSCT No drug interventions treatment 1 unknown_status NCT05104684
Chest Physical Therapy in Patients Waiting for Allogeneic Hematopoietic Stem Cell Transplantation" No drug interventions treatment Not Available completed NCT04247945
Co-transplantation of MSC in the Setting of Allo-HSCT No drug interventions prevention 2 / 3 recruiting NCT03148197
Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT) No drug interventions Not Available Not Available unknown_status NCT02993783
A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) treatment 2 terminated NCT03593161
Humor Therapy and Distress After Allogeneic Stem Cell Transplantation No drug interventions supportive_care Not Available unknown_status NCT06028828
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation treatment 2 recruiting NCT03297528
Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant No drug interventions prevention 2 unknown_status NCT03256071
Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT treatment 2 / 3 unknown_status NCT04713956
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT treatment 2 / 3 unknown_status NCT04822532
Precision Dosing of Busulfan in Children Undergoing HSCT No drug interventions treatment Not Available recruiting NCT02744742
G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT treatment 2 / 3 completed NCT05727917
Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation treatment Not Available recruiting NCT04372524
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study No drug interventions Not Available Not Available recruiting NCT05674539
Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome treatment 3 recruiting NCT00429039
A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation No drug interventions treatment 2 terminated NCT03384225
CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML treatment 3 unknown_status NCT03624530
Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants treatment 2 / 3 unknown_status NCT05149365
Sitagliptin for Prevention of aGVHD After Alternative Donor Transplantation prevention 3 recruiting NCT01379391
Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT treatment 4 unknown_status NCT04123392
Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT treatment 2 / 3 unknown_status NCT05809167
Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT No drug interventions treatment 2 recruiting NCT05379569
Comparative Study of BFC and BuCy Conditioning Regimen for Allo-PBSCT in Acute B-cell ALL treatment 4 recruiting NCT05596981
The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT Not Available Not Available recruiting NCT05601895
The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib Maintenance Not Available Not Available recruiting NCT02312830
Belgian Cross-sectional Allogeneic Transplant Survivor Study No drug interventions Not Available Not Available enrolling_by_invitation NCT03605953
Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available unknown_status NCT02048800
Treosulfan Pharmacokinetics in Children Undergoing Allogeneic HSCT Not Available Not Available completed NCT00169728
Vaccination of Children Following Allogeneic Stem Cell Transplantation prevention 3 completed NCT00990249
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation treatment 2 completed